Literature DB >> 2723268

Determinants of exercise capacity in hypertrophic cardiomyopathy.

M P Frenneaux1, A Porter, A L Caforio, H Odawara, P J Counihan, W J McKenna.   

Abstract

Exercise capacity in hypertrophic cardiomyopathy is thought to relate to elevated left atrial pressure as a consequence of impaired diastolic function, but this assumption has not previously been evaluated. Twenty-three patients with hypertrophic cardiomyopathy underwent hemodynamic assessment during symptom-limited maximal exercise with objective measurement of exercise capacity by respiratory gas analysis. Maximal oxygen consumption and anaerobic threshold were 28.1 +/- 7.5 and 21.5 +/- 6.1 ml/kg per min, respectively (the lower limit of reference range in our laboratory is 39 and 27 ml/kg per min, respectively). Maximal oxygen consumption was reduced in 11 of 13 patients who were in New York Heart Association functional class I and who denied limitation of exercise capacity and in all 10 patients who were in functional class II or III. Maximal oxygen consumption and anaerobic threshold were related to peak cardiac index (r = 0.650, p less than 0.001 and r = 0.459, p = 0.03, respectively) and to the increase in cardiac index on exercise (r = 0.677, p less than 0.001 and r = 0.509, p = 0.016, respectively), but not to cardiac index at rest, peak and rest pulmonary capillary wedge pressure, pulmonary capillary wedge pressure at an oxygen consumption of 15 ml/kg per min or the rise in pulmonary capillary wedge pressure on exercise. These findings are not consistent with the hypothesis that elevated left atrial pressure is the major determinant of exercise capacity in patients with hypertrophic cardiomyopathy and they suggest that, as in patients with chronic cardiac failure, other mechanisms should be considered.

Entities:  

Mesh:

Year:  1989        PMID: 2723268     DOI: 10.1016/0735-1097(89)90342-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Health related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy.

Authors:  S Cox; A C O'Donoghue; W J McKenna; A Steptoe
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

2.  Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy.

Authors:  Georgios K Efthimiadis; Areti Hitoglou-Makedou; Georgios Giannakoulas; Anastasia Mitakidou; Theodoros Karamitsos; Haralambos Karvounis; Sotirios Mochlas; Ioannis Styliadis; Haris Stefanidis; Georgios Parcharidis; Georgios Louridas
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

3.  Effects of exercise on the duration of diastole and on interventricular phase differences in patients with hypertrophic cardiomyopathy: relationship to cardiac output reserve.

Authors:  Gunnar Plehn; Julia Vormbrock; Axel Meissner; Hans-Joachim Trappe
Journal:  J Nucl Cardiol       Date:  2009-01-22       Impact factor: 5.952

4.  Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity.

Authors:  Y Matsumura; P M Elliott; M S Virdee; P Sorajja; Y Doi; W J McKenna
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

5.  Heart Failure with Preserved Systolic Function.

Authors:  Michael Domanski; Eliot Peyster
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-05

Review 6.  The role of exercise testing in the evaluation of the patient with hypertrophic cardiomyopathy.

Authors:  S Firoozi; S Sharma; W J McKenna
Journal:  Curr Cardiol Rep       Date:  2001-03       Impact factor: 2.931

7.  Elevated carbohydrate antigen 125 levels in hypertrophic cardiomyopathy patients with heart failure.

Authors:  Ercan Varol; Mehmet Ozaydin; Ahmet Altinbas; Suleyman M Aslan; Abdullah Dogan; Ozkan Dede
Journal:  Heart Vessels       Date:  2007-01-26       Impact factor: 2.037

Review 8.  Cardiopulmonary Exercise Test in Patients with Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis.

Authors:  Adrián Bayonas-Ruiz; Francisca M Muñoz-Franco; Vicente Ferrer; Carlos Pérez-Caballero; María Sabater-Molina; María Teresa Tomé-Esteban; Bárbara Bonacasa
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

9.  Relationship between baseline resting diastolic function and exercise capacity in patients with hypertrophic cardiomyopathy undergoing treadmill stress echocardiography: a cohort study.

Authors:  Wael A Aljaroudi; Milind Y Desai; M Chadi Alraies; Maran Thamilarasan; Venu Menon; L Leonardo Rodriguez; Nicholas Smedira; Richard A Grimm; Harry M Lever; Wael A Jaber
Journal:  BMJ Open       Date:  2012-12-12       Impact factor: 2.692

10.  Echocardiographic predictors of severe heart failure symptoms in hypertrophic cardiomyopathy patients with sinus rhythm.

Authors:  Fatih Bayrak; Gokhan Kahveci; Muzaffer Degertekin; Bulent Mutlu
Journal:  Trials       Date:  2008-02-29       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.